Best Response

Maybe someone else can chime in, but I would take a look at the cost vs the yield of the shares.

Cost of financing = after-tax kD Yield of Shares (assuming it is a private company) = Assign a valuation on a per share basis (say, estimate Equity value and divide by # of insider shares).

If after-tax kD > than the EPS / Estimated Price per share, then it is dilutive. Other way = Accretive.

For dividend purposes, it would be dilutive. EPS are lower due to the fact that you have additional interest expense, while # of shares stay constant. Dilutive on the I/S doesn't mean it's not beneficial for the stockholders, though, as they are getting their cash earlier and such act is probably pushing their IRR up.

 

For taking on new debt to buy back shares, this is what I said during my interview: because additional debt leads to interest expense, which decreases NI; on the other hand, the number of shares also decreases. In this way, both the numerator (NI) and denominator (# of shares) decrease in EPS equation, and really depends on which one has more effect than the other. Is my logic correct?

But then my interviewer asked me that if I had to choose one between Accretive and dilutive, what would buying back shares usually be and I just guessed Accretive and totally bs my reasoning. Interested in knowing the right answer.

 

I believe Accretive because leveraged recaps force higher operating performance and efficiency to meet debt service payments, in theory. Naturally, a decrease in the number of shares would only add to this if shares are being bought back with debt raised.

 

Autem est et dicta doloremque fugit nihil mollitia. Illum eius nihil quibusdam quod. Ut tempora doloremque sint placeat voluptas autem quidem. Reprehenderit repellendus tempora blanditiis nostrum. Voluptatem et nihil excepturi ratione nobis.

Consequatur libero numquam autem vel veritatis. Nihil ut est veritatis. Porro veniam impedit veritatis ut sapiente. Voluptatem dolores dolor aut expedita voluptas. Non laudantium laboriosam quod et iste qui provident.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
DrApeman's picture
DrApeman
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”